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Currently, cell separation occurs almost exclusively by density
gradient methods and by fluorescence- and magnetic-activated
cell sorting (FACS/MACS). These variously suffer from lack of
specificity, high cell loss, use of labels, and high capital/operating
cost. We present a dielectrophoresis (DEP)-based cell-separation
method, using 3D electrodes on a low-cost disposable chip; one
cell type is allowed to pass through the chip whereas the other is
retained and subsequently recovered. The method advances usabil-
ity and throughput of DEP separation by orders of magnitude in
throughput, efficiency, purity, recovery (cells arriving in the correct
output fraction), cell losses (those which are unaccounted for at
the end of the separation), and cost. The system was evaluated
using three example separations: live and dead yeast; human
cancer cells/red blood cells; and rodent fibroblasts/red blood cells.
A single-pass protocol can enrich cells with cell recovery of up to
91.3% at over 300,000 cells per second with >3% cell loss. A two-
pass protocol can process 300,000,000 cells in under 30 min, with
cell recovery of up to 96.4% and cell losses below 5%, an effective
processing rate >160,000 cells per second. A three-step protocol is
shown to be effective for removal of 99.1% of RBCs spiked with
1% cancer cells while maintaining a processing rate of∼170,000 cells
per second. Furthermore, the self-contained and low-cost nature of
the separator device means that it has potential application in low-
contamination applications such as cell therapies, where good
manufacturing practice compatibility is of paramount importance.
dielectrophoresis | DEP | lab on a chip | FACS | MACS
Since the separation of red and white blood cells was firstreported in 1974 (1), the technology has become funda-
mental in the biomedical sciences. From isolation of diseased
tissue to the identification of cells for therapeutic uses and the
potential for regenerative cell-based therapies, cell-separation
techniques are increasingly integrated into other fields such as
biochemistry, electrical engineering, physics, and materials sci-
ence (2). Three methods dominate cell separation. Density gra-
dient methods exploit differences in density between populations
such as red/white blood cells. Fluorescently activated cell sorting
(FACS) uses fluorophore-conjugated antibodies as a discrimina-
tor; cells are launched in droplets, each containing one cell,
through a fluorescence detection system to determine the cell type
and are then electrostatically diverted into different output re-
ceptacles (3). FACS can sort up to 50,000 cells per second, with
higher rates achievable at the cost of purity. Finally, magnetically
activated cell sorting (MACS) uses magnetic microbeads conju-
gated with antibodies. These bind to targets on cell surfaces, which
then can be extracted by applying a magnetic field (4).
However, the three methods have drawbacks. Only density
gradient does not require the use of chemical labels; the others
use fluorescent chemicals or antibodies to indicate the target
population. These are expensive and may have limited specific-
ity; in the case of MACS, the target protein must be present on
the surface of the cells. Following separation, the labels may also
persist in the cells, limiting their usefulness. Cell losses in FACS
and MACS can exceed half the population, particularly at high
sorting rates (5, 6). FACS machines (particularly high-throughput
devices) are very expensive and are not easily cleaned, rendering
cell populations separated by this method noncompliant with good
manufacturing practice (GMP). Finally, as the cell preparation
includes a period during which labels are added and then given
sufficient time to conjugate, the total time to perform the sort can
extend over several hours.
There have been many attempts to develop cell-separation
techniques that are affordable to buy and use, do not require
labels, and are able to retain significant numbers of cells. An
alternative separation technique is dielectrophoresis (DEP). A
polarizable particle suspended in a nonuniform electric field (7)
interacts with the field gradient, inducing a dipole. The inter-
action of dipole and field gradient produces different Coulomb
forces on either pole, inducing motion up or down the high field
gradient according to the polarity of the dipole. The magnitude
and polarity of the dipole itself are governed by the electrical
properties of the cell (resistance and capacitance of membrane
and cytoplasm) and medium, and the frequency of the electric
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field. DEP can be used both to characterize and separate cells
according to the passive electrical properties, where two cell
types experience a field gradient at a frequency such that one cell
type is attracted to the electrodes, one repelled. The repelled
cells pass through the device unaffected, but the others are
attracted to, and retained by, the electrodes acting as an “elec-
trostatic filter.” When the field is removed, these cells are re-
leased and can be collected separately. For example, Fig. 1 shows
spectra of two identical cell types, save that one has double the
membrane capacitance of the other. The highlighted frequency
range indicates where one cell type experiences positive DEP,
the other negative. DEP spectra can be determined by com-
mercial devices such as the DEPtech 3DEP, and exploitable
differences can be readily identified by visual inspection.
DEP separation of live and dead yeast cells was first demon-
strated in 1966 (8). Subsequent research demonstrated separation
of cancerous and healthy cells, Gram-negative and Gram-positive
bacteria, stem-cell subpopulations, and different types of viruses
for sample preparation, whereas differences between cells in-
dicated the potential for DEP to fractionate leukocyte subpopu-
lations (9–20). However, few approaches to DEP have been able
to compete with MACS or FACS: (i) implementations often
suffer from cells being trapped in interconnecting tubing, devices
requiring small chamber heights to ensure cells pass close to the
electrodes, restricting throughput and ultimately limiting total
cell capacity; and (ii) the high cost of manufacturing, making it
difficult to mass-produce the separator as a reliable, disposable
component. There are exceptions; the ApoStream method (21) can
isolate significant numbers of circulating tumor cells from 12 mil-
lion nucleated peripheral blood cells in 60 min (5,000 cells per
second). Hu et al. (22) reported separating 10,000 cells per sec-
ond, but required the use of chemical labeling. Lee et al. (23)
reported a rate of 616 cells per second. Markx et al. (24) pro-
cessed live and dead yeast cells at 107 cells per milliliter with
purity in excess of 93%; however, the total capacity of the device
was only 50 μl, limiting overall throughput. An alternative ap-
proach to DEP separation used 3D chips constructed from in-
terleaved conducting and insulating sheets with holes or “wells”
drilled through (25). The first prototype sorted 50:50 live and
dead yeast to 86:14 at 0.4 mL min−1. A subsequent design (26)
included remixing by passing through multiple wells, producing
high cell recovery (>90) but low throughput (25 μL min−1).
To be comparable to FACS or MACS requires cell sorting at
rates in excess of 105 s−1 with minimal cell loss, high purity, low
cost, and highly robust. Here we describe an electrophysiology-
activated cell enrichment (EPACE) method using a chip with
397 holes of 400-μm-diameter drilled through a laminate of
12 conducting layers separated by insulators, through which
397 wells of 400-μm-diameter were drilled. As shown in Fig. 2,
this creates 397 parallel paths through the chip, each with
12 electrodes along the bore. This high degree of parallelization,
and the fact that all cells are no more than 200 μm from the
electrodes, allows very high cell-processing rates while minimiz-
ing cell loss, and creates immunity from bubbles (which will, at
worst, block only one channel). Consequently, the system can
separate cells at rates substantially in excess of 320,000 cells s−1
measured across all cell types studied, separating populations in
excess of 108 cells into output receptacles in under 30 min with
cell losses as low as 0.3%, and separation efficiencies as high as
96.4%, achieving more than 30× higher throughput of previous
DEP devices.
Results
Cell Enrichment Using a Single-Pass Protocol. To assess separation
efficacy, binary mixtures of cells were processed through the
device in 5–15-mL units, processed at between 15,000 and
33,000 cells per second, the results of which are summarized in
Fig. 3. Live and dead yeast showed mean recovery (the pro-
portion of cells output in the correct outlet) of 81.3% and 89.5%,
respectively; vole blood and fibroblasts showed separation effi-
ciencies of 87.3% and 73.9%, respectively. Purities (the proportion
of required cells in the output population) at the output for the
above populations were 91.3% and 78.2% for live and dead yeast,
and 75.6% and 86.4% for vole RBCs and fibroblasts. Whereas
these values are low when considering the technique as a separa-
tion per se, they represent sufficiently high values to constitute
effective cell enrichment. It is also significant that for the above
Fig. 1. DEP spectra of two arbitrary cell types, whose properties are iden-
tical save for one (blue line) having a membrane capacitance twice that of
the other (red line). In the frequency band (highlighted), the polarizabilities
(and hence direction of force) of the two cells is different, enabling the cells
to be separated.
Fig. 2. (A). Photograph of the DEP separation chip. The chip size is 30 mm × 20 mm. (Inset) Red section shows a close-up of the chip, showing the electrodes
along the inside of the wells. The section of the chip in the image is ∼5 mm square. (B) Schematic of the chip, showing the three modes of DEP behavior. Cells
flow from top to bottom through the wells; in the left well, cells can be seen experiencing positive DEP, are attracted to the electrodes, and held; in the center
well, cells experience negative DEP, are repelled into the center of the well, and pass through. In the third well, cells experience no DEP force. In reality, cells
of the same type will experience the same mode of behavior in all wells on the chip, but two different cell populations can exhibit behaviors different from
each other. If one subpopulation experiences positive DEP and the others exhibit negative or neutral behavior, they can be separated. (C) The chip is loaded
into a fluidic cartridge comprising two parts; an upper part B contains both housing and plunger, whereas a lower part A collects the cell solution. The chip fits
between the two, sealed on both sides by O rings, and is clamped together by three Allen bolts.
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population sorts, the mean cell losses (cells which were input but
are unaccounted for at the output, due to damage, adherence to
the electrodes or device casing, or being left in residual liquid in
the device at the end of the experiment) were 1.4%, 2.7%, 4%,
and 0.3%, respectively. These low cell losses are important for two
reasons; first, multiple passes can be used to improve performance
without significantly degrading cell numbers; second, unlike
methods such as FACS, where a significant number of cells being
separated are destroyed by the separation process (6), this protocol
does not reduce cell number––an important issue where initial
cell numbers are low. Experiments at 0.5, 0.8, and 1.0 mL min−1
yielded similar results, suggesting these metrics represented a
plateau of trapping efficiency, and that the device was working
well within its performance limit.
To assess the viability of cells postsort, collected fibroblasts
were suspended in fibroblast-growing medium, divided into two
T75 flasks, and placed in the incubator to assess growth poten-
tial. The cells were observed 1 and 3 d after incubation and were
found to have adhered to the flask and reached confluency, re-
spectively. A DEP spectrum of the cells was obtained and a
further passage performed to check for abnormalities; none
was observed.
To identify the upper-throughput limit, live yeast cells were
captured in the device in increasing concentrations, as it is the
fraction of cells experiencing positive DEP that is limited by the
capacity and efficacy of the DEP electrodes (the other, repelled,
population simply passing through the device unaffected). Retain-
ing the 1-mLmin−1 flow rate, the concentration of cells per milliliter
was increased from 106 mL−1 to ∼2 × 106, 5 × 106, 107, 2 × 107, and
108 cells per milliliter. Chip saturation was monitored in two ways:
first, we measured the total number of cells retained in the chip
and subsequently recovered. Second, cells were aliquoted in
1-mL fractions and analyzed to determine the cell ratio to ob-
serve trap saturation. Saturation can then be detected by the
appearance of a higher proportion of live cells in the output
stream. Any saturation effect would only affect cells collected by
positive DEP on the electrodes; cells experiencing zero or neg-
ative DEP pass through the chip unimpeded and are collected in
the receptacle below, and as a consequence there is no saturation
limit on such cells.
At concentrations up to 2.7 × 107 mL−1 the device worked as
for 1 × 106 mL−1. When concentrations of 2.7 × 107 mL−1 were
used, the aliquots were normal and the mean cell recovery was
279 ± 12.2 million cells. When the input concentration was 5.9 ×
107 mL−1, the number of cells increased dramatically (by over
300%) at the sixth aliquot, and the mean total of recovered cells
was 321 ± 9.0 million cells; when 1.07 × 108 mL−1 were used, the
device became saturated after the third aliquot (rising by 38% in
aliquot 4, rising to >100% in aliquot 7 and later), and recovery
indicated that the trap contained 359 ± 13.3 × 106 cells. After the
separation run was completed, the cells collected in the chip
were flushed and counted. In the three instances where the chip
was saturated, the number of cells retained before the chip was
saturated, with upper limits of ∼350 × 106 cells representing the
capacity of the chip.
The difference in capacity between 59 million and 109 million
cells per milliliter is interesting, as it suggests the trap capacity
may be increased at high concentrations due to cell–cell inter-
actions; however, it appears clear that a 300 × 106 cell sort
(20 million cells per milliliter, 15 mL total volume) represents
the maximum effective cell separation where the cell content is
entirely unknown, although this represents the limit only on the
positive DEP fraction; a sort of 300 million cells experiencing
positive DEP from a further 300 × 106 (or more) experiencing
negative DEP would in principle be entirely workable, raising the
throughput past 0.6 × 109 cells per milliliter.
High-Volume Separation Performance Using Multipass Protocols.
Whereas enrichment on this scale is of interest, a second or
third pass through the device enables the user to collect cells that
were not retained in previous passes, significantly improving per-
formance in a very short time. There are two strategies for multiple
sorting passes: re-sorting the effluxed and retained cells, respec-
tively. Here we examine these two protocols separately: a two-pass
strategy reprocessing the effluxed cells to minimize cell loss while
maximizing enrichment in the shortest possible time, and a three-
pass strategy where the collected cells are reprocessed.
Enhancing the negative DEP population. We sorted mixtures of 9.6–
14 × 106 cells (similar to the cell number in a confluent
T175 flask) at concentrations of 1–2 × 106 cells per milliliter and
passed through the EPACE twice. After each run, the chip was
flushed with fresh medium to recover cells retained by positive
DEP before the output was reprocessed. Negative DEP was used
to select the dead cells from mixtures of live and dead yeast cells,
or RBCs from mixtures of RBCs and fibroblasts, the results of
which can be seen in Fig. 4. After the second pass the purity of
dead yeast was increased to 93.4% while the RBC fraction in-
creased to 93.8%. However, recovery was reduced, falling to
81% and 73.7%, respectively, although these are still substantially
above recovery rates for FACS and MACS. Overall cell losses
(cells not appearing in either outlet) were 2.7% and 4%, with the
remaining cells appearing in the other (waste) output. We postu-
lated that the values of separation efficiency for the populations
experiencing negative DEP were adversely affected by cells being
trapped in the dead volume between the chip and outlet, which
were then recovered with the retained cells rather than passing to
the effluxed portion. To verify this, we performed a separation of
20 mL of RBC/fibroblast cells at the same concentration. After the
second pass, the recovery of RBCs was broadly similar at 87.8%,
but the purity rose to 96.6%.
Enhancing the positive DEP population. An important application of
cell separation is the enrichment of relatively rare subpopula-
tions. To use the EPACE platform to enrich highly asymmetrical
cell concentrations a three-pass strategy was used, with the cell
fraction retained in the electrodes being retrieved and then
subject to two further iterations (total time taken ∼30 min). The
Fig. 3. Average (n = 3) results of the enrichment of mixtures of (A) live and
dead yeast and (B) RBCs and fibroblasts, showing the total cell number in
each case. “Initial” refers to the numbers at the start of separation, “passed”
represents the cells collected during the separation, “recovered” represents
those cells collected by positive DEP and subsequently removed, and “lost” is
those unaccounted for. Cells were processed through the device at ∼1 million
cells in 1 mL/min.
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cells collected were counted after each pass, and the ratio of cell
types was determined. These results are summarized in Fig. 5.
Human RBCs were spiked with MDA-MB-231 breast cancer cells,
to a final concentration of 1.1% cancer to 98.9% RBCs, at a total
cell concentration of ∼2 × 107 mL−1, to a total sample volume
of 4 mL. Cells were passed through the device at 0.5 mL min−1.
After the cell mixture had completed its first pass through the
device, the fraction retained in the device was released in 1 mL
of fresh medium, which was topped up to 3 mL with fresh
medium after cell counting. Sampling indicated that the con-
centration of RBCs had dropped to 95.5% of the output. The
3 mL of solution was then subject to a second pass and resus-
pension, at which point RBCs had dropped to 75.6%, and after
the third pass, RBCs made up 59.5% of the cell sample, with
cancer cells forming the remaining 40.5% of the cells, an ef-
fective removal rate of the RBCs of 99.1%. At the end of the
process, on average 47.7% of the initial population of cancer
cells were recovered. However, those that had not been col-
lected in the initial sort would be available for resorting in the
waste from the previous passes, which could be used to signif-
icantly increase cell recovery if required, by adding an addi-
tional pass on the eluted cells.
Discussion
Analysis of Performance.Whereas purity of sample at output is the
final arbiter of the quality of a separation/enrichment method, it
is difficult to use as a guide as it depends on the concentration of
the two cell types at the input. Instead, we can look at the con-
centration of both the desired and undesired cells. Analyzing the
two-pass protocol to enrich live and dead yeast and RBC/fibro-
blast cells by negative DEP, the population experiencing nega-
tive DEP has recovery of ∼90% for the desired cells and 20% for
the undesired fraction for each round of enrichment. After two
passes, these are approximately squared, such that ∼0.81× the
desired and 0.04 undesired cells are present at the output,
leading to a purity of 0.81/(0.81 + 0.04) = 95.3%, in line with
experimental results. Similarly, for enrichment of cells experi-
encing positive DEP, across the three rounds of separation the
same process was observed, with an average of ∼80% of MDA
cells and 20% of RBCs appearing at the output for each round
of enrichment. Over successive passes, this predicts RBC pro-
portions of 96%, 86%, and 60%, in line with observations. The
cell losses are sufficiently low for them to be disregarded in
the calculation.
Effect of Design on Optimum Performance. From our results, it is
possible to identify ways to optimize the cartridge design and
increase separator performance by improving the values of cell
recovery for the wanted and unwanted cells. Notably, whereas
the peak values of recovery and purity are high, it is the passed
cells that have the highest purity, whereas retained cells always
have the highest recovery. As configured, the device contains two
“dead volumes” of sample that cannot be recovered at the end of
the experiment. One occurs due to the use of a conical syringe
plunger; at maximum insertion the tip of the cone touches the
chip and 0.56 mL of unseparated cells remain surrounding the
plunger tip. Similarly, ∼0.54 mL of postseparation cells remain in
the space between the chip and outlet. Consider a mixture of two
populations A and B, where population A experiences negative
DEP and passes through the chip while population B is retained
by positive DEP; the mixture is contained in a 10-mL sample.
After the solution is passed through, 1.1 mL (11%) of cells re-
main in the dead volume, limiting maximum recovery of A to
89%. However, purity is unaffected because only the cells which
have been passed through by the chip are collected. When the
Fig. 4. Average (n = 3) results of a second stage of separation of mixtures of
(A) live and dead yeast and (B) RBCs and fibroblasts, showing the total cell
number in each case. For the second step, the cell population experiencing
negative DEP was reprocessed. “Initial” refers to the numbers at the start
of separation, “outlet” represents the cells collected during the separation,
“waste” represents those cells collected by positive DEP and subsequently re-
moved, and “lost” is those unaccounted for. Cells were processed through the
device at 1 mL/ min−1; with an initial cell concentration of ∼1 million cells per
milliliter.
Fig. 5. Enrichment of MDA cancer cells cancer cells from RBCs, at an initial
ratio of 1:99, average (n = 3) results using a three-pass protocol. (A) The
percentage of RBC cells in the sample, per run. (B) The mean (n = 3) overall
recovery of the two cell types after each stage; the recovery of RBCs reaches
99.1%, suggesting that the cancer cells have been significantly enriched.
4 of 6 | www.pnas.org/cgi/doi/10.1073/pnas.1700773114 Faraghat et al.
solution has been processed, we then draw 1 mL into the device
and release population B. However, the device also contains
1.2 mL of the original cell mixture, containing cells from
population A. This means that the recovery rate for mixture B is
as high as can be obtained (because all of the cells are in the
extracted volume), but the purity is downgraded by the presence
of population A cells in the dead volumes. In effect, the dead
volumes act to take cell mixtures intended for the output for
population A, and deposit them in the output to population B.
Whereas a future embodiment of the device could reduce the
dead volumes by redesigning the plunger and outlet path, we can
calculate the effective peak separation by mathematically re-
moving the cells in the dead volumes. We estimate that using this
approach, the recovery of RBCs and purity of fibroblasts in the
separation described above would equal or exceed the same
parameters for the two parameters unaffected by the dead vol-
umes, which is to say that all purities and recoveries would ex-
ceed 95% for a two-pass strategy.
The design outlined in this paper is a proof of concept, but a
number of design modifications suggest themselves to improve
simplicity, throughput, and capacity. For example, the device
presented here is loaded manually by drawing the syringe
plunger upward. This means there is little control of the flow rate
during loading; hence, during this time the chip is not energized.
However, with the application of a bidirectional syringe pump
that can both push and pull, it would be possible to separate on
both draw and expel cycles, making separation simpler and more
efficient. The single inlet of the cartridge also lends itself to
combining with simple liquid handing /fraction collection sys-
tems, allowing automation of complex multipass protocols
without user intervention. It is also evident that the design pre-
sented here could be modified to increase throughput. For ex-
ample, a second chip, independently energized, could be
mounted below the first to permit a second stage of separation;
this could either be at the same frequency as the first, doubling
the separation rate by removing the necessity for two separation
passes, or at a different frequency to allow two-parameter sort-
ing, while requiring no further antibodies (as would be required
for FACS and MACS), making for a negligible cost increase over
a single-chip version. Similarly, the throughput and total cell
capacity could be increased by enlarging the chip and increasing
the number of wells; this could be achieved by making a single
electrode disk larger, or otherwise increasing the number of wells
For example, a chip with ∼3,500 wells could potentially separate
up to 1010 cells in a similar 30-min period, potentially allowing
separation on industrial scales, or clinical applications such as
sorting of stem cells from bone marrow.
Comparison with Other Separation Methods. As described earlier,
cell-separation methods requiring more sensitivity than density
gradients can be addressed by two methods: FACS and MACS.
A high-throughput FACS system is expensive; both FACS and
MACS require expensive labels, and can only separate cells on
the basis of this labeling. The EPACE system presented here
separates on the basis of physical parameters without the need
for labels, and both the instrumentation (pump and generator)
and consumables required (media, chips) are an order of mag-
nitude less expensive than either method. Furthermore, the
system presented here could be manufactured as a fully assem-
bled, sterile, integrated cartridge; with no cross-over possible
with other reparation runs and no residual chemical labels to
adversely affect cells, this allows the cells produced to be fully
compliant with GMP.
Cell-throughput rates also compare well with other methods.
High-throughput FACS cell sorters can process up to
100,000 events per second, although a relatively small proportion
of these may actually contain cells. MACS is a bulk method
rather than processing cells serially, but the time taken to pre-
pare and perform separation is comparable to the method pre-
sented in this paper. Similarly, the number of cells to be
separated by high-volume MACS systems is 109 cells; although
no upper limit for FACS has been identified, a wide review of the
literature reports few studies exceeding 2 × 107 cells. Baseline
EPACE performance is comparable to MACS, and better than
FACS. For example, the capacity of the device is ∼4 × 108 yeast
cells; balancing the relatively small size (and hence higher
packing density) of such cells against the fact that DEP trapping
force scales with cell volume, a capacity of >108 mammalian cells
is certainly not unreasonable. In terms of throughput, if we di-
vide the number of cells processed by the time required for a
two-pass sort, we have an effective sorting rate of 167,000 cells
per second; adding in a third sort, as in the case of the rare cell
study, still gives a net throughput comparable to high-throughput
FACS. Considering cell loss, EPACE is shown to be comparable
to, or better than, either existing method. In no case were more
than 7% of cells lost, and in many cases fewer than 3% of cells
were lost. By comparison, FACS typically loses >50% of cells
through cell damage during droplet formation or rejection due to
incorrect scanning, particularly at higher flow rates (5). When
used in three-pass mode, cell recovery was lower, but the cells
not initially captured by the device will be available for resorting
in the outlet stream by using a more complex multiple-run
separation strategy.
Comparing our method to published DEP methods, the
EPACE process is 30× faster than the Hu et al. (22) system, 6×
faster than the Gupta et al. (21) system, and 600× faster than the
system presented by Lee (23), with comparable or better cell
recovery and cell losses. The cell concentration and recovery
were comparable to the Markx et al. system (24); without addi-
tional data we cannot compare throughput or cell loss. As these
devices were microfluidic, we suggest that the system presented
here should be significantly more robust; whereas the function of
planar microfluidic devices can be compromised by the presence
of a single bubble, the highly parallel design of our chip means
that if a bubble appears it has no more effect than potentially
blocking just one of the 397 holes.
Unlike FACS and MACS, which sort cells on the basis of
specific recognition of membrane proteins, DEP separates on
the basis of differences in the electrophysiology of the two cell
types. This offers advantages over these existing methods, as
many differences in cell types (and changes in cells in response to
external stimuli) exhibit corresponding differences in the cell’s
electrophysiome. Examples have included the differentiation of
neural stem cells, where electrical changes in the membrane al-
low sorting of cells according to differentiation fate far in ad-
vance of conventional marker-based methods, e.g., refs. 27–29;
indeed, stem-cell sorting may be an area where DEP-based
separation may dominate over existing methods, whereas DEP
Fig. 6. Schematic showing the separation procedure, which is divided into
three steps. In step 1, a mixture of cells is drawn into the syringe through the
chip. In step 2, the chip is activated and cells are expelled at typically
1 mL min−1. One cell type is retained in the electrodes while the other is
eluted. In step 3, after the solution is fully expelled, fresh medium is drawn
into the device and expelled manually at a higher rate while the retaining
field is deactivated, allowing the retained cells to be collected.
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separations in cancer cells have been reported for some decades
(13), both for diagnosis and development of interventions. Many
other cases of differential DEP response have been identified in
the past 50 y, and all past demonstrations can be performed
using this platform (30). Once differential electrophysiology is
established by DEP profiling, it can be exploited through the use
of ion channel blockers to emphasize difference and enhance
DEP separation (31).
In conclusion, we have presented a DEP-based cell-separation
technique that has a capacity and throughput comparable to the
fastest MACS and FACS machines, requires no chemical labels,
offers GMP compatibility, significantly lower cell loss, and sig-
nificantly lower capital and running costs. Given the opportunity
to exploit differences in cell electrophysiology in fields such as
stem-cell therapy and cancer, we believe this offers significant
promise as a new standard benchtop laboratory technique.
Materials and Methods
Experiments followed the steps outlined in Fig. 6. The cartridge and chip
were cleaned with ethanol before assembly. The chip manufacture and cell
mixtures are described in Supporting Information. A sample containing a
mixture of the two cell types A and B was loaded into the fluidic cartridge by
inserting the tube into the solution, then manually withdrawing the plunger
to load the reservoir. This was then placed in a vertically mounted syringe
pump (Razel, maximum output of 1 mL min−1), and the solution was pumped
through the chip while voltage was applied to the electrodes using a
signal generator (Jupiter 2000, Blackstar), connected to the chip via a
custom-made amplifier board to supply up to 18 peak-to-peak voltage at
frequencies up to 1 MHz. The output (enriched for population A) was col-
lected in a second receptacle. Then fresh solution was loaded into the car-
tridge, the field was deactivated, and the chip was flushed manually with
fresh medium to dislodge and recover the cells from population B that had
been collected by positive DEP. When using a second or third pass, it was
possible to enrich either cell-A or -B samples by repeating the procedure
with the enriched samples. The total time for the two-pass procedure was
under 30 min for yeast, and under 15 min for RBC/fibroblasts. Cells were
exposed to the electric field for an average of ∼5 min for the positive DEP
fraction, or under 10 s for the negative DEP fraction. All experiments were
repeated three times. For the three-pass experiments to enrich rare cells, at
the end of the second and third passes the cells were recovered by switching
the field off, manually pulling the plunger up slightly, aspirating air into the
fluidic cartridge, and expelling the retained cells in the small sample volume
that is still within the chip. Separations were evaluated for cell recovery (the
proportion of desired cells which arrive at the correct outlet), purity (the
proportion of desired cells in a given outlet), and cell loss (the number of
cells which are unaccounted for at the end of the separation). The number
of missing cells was obtained by subtracting the “passed” and “recovered”
populations from the initial number of cells.
DEP spectra of individual cell types were measured using a DEPtech 3DEP
and a separation frequency midway between the cross-over frequencies (the
frequency on the DEP spectrum where the response crosses zero) for the two
cell types to be separated; for the live/dead yeast mixture, 1 MHz was se-
lected; for the fibroblast/RBC mixture, 22 kHz was selected; and for the MDA/
RBC mixture, 76 kHz was used. Cells in output mixtures were either identified
by the use of Trypan blue (live and dead yeast) or by visual inspection of the
morphologically quite different RBCs and fibroblasts/MDAs. Work on human
and mammalian cells was approved by the University of Surrey Ethics
Committee; further details are available in the Supporting Information.
Human participants in the study were screened for relevant self-reported
health issues. All participants provided written, informed consent after
having received explanation of the various study procedures.
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